연구
교육
솔루션
로그인
KR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Institute of Neuroscience and Physiology,
Department of Psychiatry and Neurochemistry,
Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Josef Pannee has not added Biography.
If you are Josef Pannee and would like to personalize this page please email our Author Liaison for assistance.
Proteomics profiling of single organs from individual adult zebrafish.
Zebrafish Jun, 2010 | Pubmed ID: 20392139
SILAC zebrafish for quantitative analysis of protein turnover and tissue regeneration.
Journal of proteomics Dec, 2011 | Pubmed ID: 21890006
Multiplexing and multivariate analysis in neurodegeneration.
Methods (San Diego, Calif.) Apr, 2012 | Pubmed ID: 22391487
Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.
Biomarkers in medicine Aug, 2012 | Pubmed ID: 22917143
A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls.
Journal of Alzheimer's disease : JAD , 2013 | Pubmed ID: 23076076
Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum.
Clinical biochemistry Apr, 2013 | Pubmed ID: 23313081
The amyloid-β degradation pattern in plasma--a possible tool for clinical trials in Alzheimer's disease.
Neuroscience letters Jun, 2014 | Pubmed ID: 24796810
Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid.
Clinical chemistry Jul, 2014 | Pubmed ID: 24842955
Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry.
Alzheimer's & dementia : the journal of the Alzheimer's Association Jan, 2016 | Pubmed ID: 26206625
Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements.
Clinical chemistry and laboratory medicine Jul, 2016 | Pubmed ID: 26495928
CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation.
Clinica chimica acta; international journal of clinical chemistry May, 2016 | Pubmed ID: 27216941
Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study.
Brain : a journal of neurology Sep, 2016 | Pubmed ID: 27401520
Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42 /Aβ1-40 ratio - a cross-validation study against amyloid PET.
Journal of neurochemistry Aug, 2016 | Pubmed ID: 27579672
Specific Triazine Herbicides Induce Amyloid-β42 Production.
Journal of Alzheimer's disease : JAD Sep, 2016 | Pubmed ID: 27589520
Ex vivo (18)O-labeling mass spectrometry identifies a peripheral amyloid β clearance pathway.
Molecular neurodegeneration Feb, 2017 | Pubmed ID: 28219449
The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital
Sahlgrenska University Hospital
Josef Pannee1,2,
Kaj Blennow1,2,
Henrik Zetterberg1,2,3,
Erik Portelius1,2
1Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital,
2Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital,
3, UCL Institute of Neurology, Queen Square
개인 정보 보호
이용 약관
정책
연락처
사서에게 추천하기
JoVE 뉴스레터
JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
교수 리소스 센터
저자
사서
액세스
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유